Frazier Life Sciences (FLS), a longstanding healthcare investment firm focused on innovative therapeutics, today announced the closing of over $1.1 billion in capital commitments to its Public Fund ...

Rubedo Life Sciences, Inc. (Rubedo) today announced a new clinical study of investigational RLS-1496 in patients with ...

New offering connects companies, drugs, indications, trials, targets, and mode of action into a unified knowledge graph — ...

Advent Life Sciences has appointed Gail Jermyn as Investor Relations Partner, strengthening its senior leadership team as the ...

Adora Life Science (Adora) today announced that Dr. Clinton D. Morgan, MD, will be joining Adora as its full-time Chief Medical ...

The conversation focused on how a reliable patent system supports the journey from scientific discovery to patient access.

The successful IPO of Caris Life Sciences makes its founder David Dean Halbert worth an estimated $3.3 billion. Caris Life Sciences, a cancer diagnostics company based in Irving, Texas, uses gene ...

This program area explores research from the molecular to the ecosystem level, emphasizing the design and engineering of biological systems. Our work focuses on the convergence of life sciences with ...

Life sciences organizations enter 2026 with external anxieties and internal optimism. Only 41% of biopharma and medtech executives responding to a Deloitte survey say they feel optimistic about the ...

In the coming year, the life sciences industry is expected to evolve, shape, and transform under pressures from both internal and external forces. Industry leaders anticipate that, despite potential ...

The companies that successfully raise money increasingly aren’t just those with the best research or technology. They are ...